Jacques R. Mathieu
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
CDO1 is a new biomarker to discriminate aggressive forms of prostate cancer.
Journal: Oncogene
Published: November 29, 2025
Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 25, 2025
Pan-RAS inhibitor after KRASG12C treatment in pancreatic cancer?
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 11, 2025
Collective cell migration plasticity in patient-derived digestive cancer organoids is dictated by environment sensing and contractility.
Journal: Cell reports
Published: June 04, 2025
The pro-apoptotic peptide PEP-010 triggers apoptosis in pancreatic tumor models in monotherapy and in combination with gemcitabine independently of the KRAS status.
Journal: Cancer letters
Published: January 28, 2025
Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.
Journal: Nature communications
Published: September 20, 2024
KRAS, a New Target for Precision Medicine in Colorectal Cancer?
Journal: Cancers
Published: September 05, 2024
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer.
Journal: ESMO gastrointestinal oncology
Published: January 24, 2024
Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 30, 2023
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer.
Journal: Gastroenterology
Published: September 22, 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 30, 2023
Last Updated: 09/26/2026